SKI Market

Indian Indices

Sensex

84,929.36 447.55
( 0.53%)

Global Indices

Nasdaq

48,160.46 187.60
(0.39%)

Dow Jones

6,855.87 60.11
(0.88%)

Hang Seng

49,620.18 618.68
(1.26%)

Nikkei 225

9,885.23 47.46
(0.48%)

Forex

USD-INR

90.25 -0.22
(-0.24%)

EUR-INR

105.87 -0.28
(-0.27%)

GBP-INR

120.72 -0.26
(-0.21%)

JPY-INR

0.58 0.00
(-0.44%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Lyka Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500259

INE933A01014

37.0210703

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LYKALABS

228.76

269.42

EPS(TTM)

Face Value()

Div & Yield %

0.33

Back

procter & gamble health ltd

Skipper consolidated net profit rises 12.45% in the September 2025 quarter

Nov 07,2025

Net profit of Skipper rose 12.45% to Rs 37.03 crore in the quarter ended September 2025 as against Rs 32.93 crore during the previous quarter ended September 2024. Sales rose 13.70% to Rs 1261.79 crore in the quarter ended September 2025 as against Rs 1109.74 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1261.79	1109.74	14
OPM %	10.36	10.04	-
PBDT	81.34	59.36	37
PBT	62.33	44.44	40
NP	37.03	32.93	12

84,929.36 447.55 ( 0.53%)

48,160.46 187.60 (0.39%)

6,855.87 60.11 (0.88%)

49,620.18 618.68 (1.26%)

9,885.23 47.46 (0.48%)

90.25 -0.22 (-0.24%)

105.87 -0.28 (-0.27%)

120.72 -0.26 (-0.21%)

0.58 0.00 (-0.44%)